Business Description

Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Name Current Vs Industry Vs History
Cash-To-Debt 261.04
Equity-to-Asset 0.97
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 103.21
Distress
Grey
Safe
Beneish M-Score -2.19
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.48
9-Day RSI 74.82
14-Day RSI 79.12
6-1 Month Momentum % 80.69
12-1 Month Momentum % 34.31

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 33.42
Quick Ratio 33.42
Cash Ratio 31.92
Days Sales Outstanding 15057.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.7
Shareholder Yield % -0.03

Financials (Next Earnings Date:2024-05-10 Est.)

BLU's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BLU

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BELLUS Health Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.015
EPS (TTM) ($) -0.72
Beta 0
Volatility % 107.43
14-Day RSI 79.12
14-Day ATR ($) 0.054828
20-Day SMA ($) 14.668
12-1 Month Momentum % 34.31
52-Week Range ($) 6.38 - 14.76
Shares Outstanding (Mil) 126.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BELLUS Health Inc Filings

Filing Date Document Date Form
No Filing Data

BELLUS Health Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BELLUS Health Inc Frequently Asked Questions

What is BELLUS Health Inc(BLU)'s stock price today?
The current price of BLU is $14.74. The 52 week high of BLU is $14.76 and 52 week low is $6.38.
When is next earnings date of BELLUS Health Inc(BLU)?
The next earnings date of BELLUS Health Inc(BLU) is 2024-05-10 Est..
Does BELLUS Health Inc(BLU) pay dividends? If so, how much?
BELLUS Health Inc(BLU) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1